Literature DB >> 31763277

Sinonasal Mucormycosis: A to Z.

V P Singh1, Chetan Bansal1, Madhuri Kaintura1.   

Abstract

Mucormycosis caused by one of the members of Mucoraceae family, is one of the most rapidly spreading and fatal fungal infection occurring mostly in Diabetic or Immunocompromised patients especially in developing countries. 26 patients suffering from sinonasal mucormycosis admitted in SGRRIM&HS, Dehradun from January 2013 to January 2017 are discussed. Diagnosis of mucormycosis was established on strong clinical suspicion with presence of grayish black crusting on nasal endoscopy which is confirmed by histopathology examination. Immediate correction of underlying immunocompromised status with debridement with intravenous liposomal amphotericin B was done in all the 26 cases out of which 10 patients were cured. Early detection and aggressive multidisciplinary management is must for the successful treatment of mucormycosis. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Amphotericin; Invasive fungal sinusitis; Rhinocerebral mucormycosis; Rhizopus oryzae

Year:  2018        PMID: 31763277      PMCID: PMC6848679          DOI: 10.1007/s12070-018-1384-6

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  20 in total

1.  Combination therapy for mucormycosis: why, what, and how?

Authors:  Brad Spellberg; Ashraf Ibrahim; Emmanuel Roilides; Russel E Lewis; Olivier Lortholary; George Petrikkos; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

2.  Fungal infections and cavernous sinus thrombosis.

Authors:  Manish Munjal; A S Khurana
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-07

Review 3.  Pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.

Authors:  Anna Neumann; Maciej Baginski; Jacek Czub
Journal:  J Am Chem Soc       Date:  2010-12-02       Impact factor: 15.419

Review 5.  Cerebro-rhino orbital mucormycosis: an update.

Authors:  Upender Wali; Abdullah Balkhair; Abdullah Al-Mujaini
Journal:  J Infect Public Health       Date:  2012-03-27       Impact factor: 3.718

Review 6.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

Review 7.  Amphotericin B formulations: a comparative review of efficacy and toxicity.

Authors:  Richard J Hamill
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

8.  Mucormycosis: an atrocious mate of patients with diabetes.

Authors:  Anu Radha Ananthaneni; Suresh Babu Undavalli; Ram Prasad Velagapudi; Vijay Srinivas Guduru
Journal:  BMJ Case Rep       Date:  2013-05-02

9.  Rhinocerebrocutaneous mucormycosis caused by Mucor species: A rare causation.

Authors:  Snehal Balvant Lunge; Vijaya Sajjan; Ashok M Pandit; Vaibhav B Patil
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

10.  Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens.

Authors:  Parisa Badiee; Amir Arastefar; Hadis Jafarian
Journal:  Iran J Microbiol       Date:  2013-12
View more
  5 in total

1.  Endoscopic assessment of sinonasal mucormycosis with SPIES: The 'battlefield' sign.

Authors:  Viorel Zainea; Irina Gabriela Ionita; Silviu Pituru; Cătălina Pietroșanu; Andreea Rusescu; Cristian Dragos Stefanescu; Florentina Gherghiceanu; Florin Anghelina; Dragos Palade; Razvan Hainarosie
Journal:  Exp Ther Med       Date:  2021-11-25       Impact factor: 2.447

Review 2.  Climate Change Impacts on Microbiota in Beach Sand and Water: Looking Ahead.

Authors:  João Brandão; Chelsea Weiskerger; Elisabete Valério; Tarja Pitkänen; Päivi Meriläinen; Lindsay Avolio; Christopher D Heaney; Michael J Sadowsky
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

3.  COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.

Authors:  Aditya Moorthy; Tulasi Nayak; Prithvi S Bachalli; Krishna Kant Tripathi; Sunil Narayan Dutt; Preeti Kale; Prashanth Bhat; Praveen K Suresh; Rohith Gaikwad; Arjun Raju; Shreya Krishna; Arvind Conjeevaram; Sushma Mehta; Abhinav Anil-Kumar; Deepak Haldipur
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-18       Impact factor: 3.236

4.  Outcome of Open Surgery in Disease Progression of Post-COVID Rhinomaxillary Mucormycosis Treated by Functional Endoscopic Sinus Surgery and Proposed Evaluation Scale for Maxillary Sinus Disease and Osteomyelitis.

Authors:  Varsha Sunil Manekar; Abhay N Datarkar; Shramapurna Karemore; Ashlesha Ghormode; Archana Deshpande; Damyanti Walke
Journal:  J Maxillofac Oral Surg       Date:  2022-10-06

Review 5.  Epidemiology of Mucormycosis in India.

Authors:  Hariprasath Prakash; Arunaloke Chakrabarti
Journal:  Microorganisms       Date:  2021-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.